On May 14th, the Second Circuit affirmed the ten year officer and director ban imposed against Brent Bankosky, a senior director at Takeda Pharmaceuticals International, Inc. After Bankosky entered into a consent judgment with the SEC in which he neither admitted nor denied the SEC's insider trading allegations, the district court found Bankosky "unfit" to serve as an officer or director of a public company and barred him from acting as one for ten years. Because the district court considered the proper factors and committed no clear error in judgment, the Second Circuit affirmed. SEC v. Bankosky.